Join us this Thursday, 2/27, for an exciting look at the next generation of blood-based predictive biomarkers for therapy selection.

Fucose signatures in peripheral blood glycoproteins are associated with reduced clinical benefit of immune-checkpoint inhibitors in metastatic melanoma

Get in touch